For this purpose, we studied the contribution of two major ALS genes, TARDBP and FUS, in the metabolic regulation during myogenesis and differentiation, using human immortalised myoblasts with induced loss-of-function (LoF) of such genes and ALS patient-derived primary myoblasts. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.